Thrombopoietin in acute liver failure

Hepatology

Volumn 37, Issue 3, 2003, Pages 558-561

  Schiødt, Frank V ^a   Balko, Jody ^a   Schilsky, Michael ^b   Harrison, M Edwyn ^c   Thornton, Annelise ^a   Lee, William M ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; THROMBOPOIETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE ACTION; HORMONE DETERMINATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0037371143     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50113     Document Type: Article

References (27)

1. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995;74:521-525.
2. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
3. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997;89:101-107.
4. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997;27:127-131.
5. Martin TG III, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997;127:285-288.
6. Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, et al. Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 1998;13:907-913.
7. Lee WM, Schiødt FV. Fulminant hepatic failure. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott-Raven, 1999:879-895.
8. Schiødt FV, Hansen BA, Ranek L, Clemmesen JO, Ott P, Larsen FS. Thrombocytopenia in paracetamol intoxication [Abstract]. J Hepatol 1995;23(Suppl 1):125.
9. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Diseases. New York: Grune & Stratton, 1970:282-298.
10. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275.
11. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996;87:567-573.
12. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ. Regulation of thrombopoietin levels by c-mplmediated binding to platelets. Blood 1996;87:2154-2161.
13. Wolber EM, Ganschow R, Burdelski M, Jelkmann W. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. HEPATOLOGY 1999;29:1739-1742.
14. Fischereder M, Jaffe JP. Thrombocytopenia following acute acetaminophen overdose. Am J Hematol 1994;45:258-259.
15. Kornberg A, Polliack A. Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet 1978;2:1159.
16. Scheinberg IH. Thrombocytopenic reaction to aspirin and acetaminophen. N Engl J Med 1979;300:678.
17. Bihari D, Gimson AE, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985;13:1034-1039.
18. Wolber EM, Fandrey J, Frackowski U, Jelkmann W. Hepatic thrombopoietin mRNA is increased in acute inflammation. Thromb Haemost 2001;86:1421-1424.
19. Colarizi P, Fiorucci P, Caradonna A, Ficuccilli F, Mancuso M, Papoff P. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr 1999;88:332-337.
20. Wolber EM, Jelkmann W. Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B. J Interferon Cytokine Res 2000;20:499-506.
21. Ishiguro A, Suzuki Y, Mito M, Shimbo T, Matsubara K, Kato T, et al. Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br J Haematol 2002;116:612-618.
22. Hobisch-Hagen P, Jelkmann W, Mayr A, Wiedermann FJ, Fries D, Herold M, et al. Low platelet count and elevated serum thrombopoietin after severe trauma. Eur J Haematol 2000;64:157-163.
23. Bjerre A, Ovstebo R, Kierulf P, Halvorsen S, Brandtzaeg P. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts. Clin Infect Dis 2000;30:643-647.
24. Stockelberg D, Andersson P, Bjornsson E, Bjork S, Wadenvik H. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J Intern Med 1999;246:471-475.
25. Sezai S, Kamisaka K, Ikegami F, Usuki K, Urabe A, Tahara T, et al. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol 1998;93:80-82.
26. Faeh M, Hauser SP, Nydegger UE. Transient thrombopoietin peak after liver transplantation for end-stage liver disease. Br J Haematol 2001;112:493-498.
27. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000;69:70-75.